NRD
WGS icon

Nebula Research & Development’s GeneDx Holdings WGS Stock Holding History

Nebula Research & Development’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,918
Closed -$378K – 1162
2024
Q4 		$378K Buy
+4,918
New +$344K 0.04% 649

Other funds holding WGS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Nebula Research & Development's WGS Position: Q1 2025 in Review

Nebula Research & Development sold out of GeneDx Holdings (WGS) in Q1 2025, closing a stake of 4,918 shares — an estimated $378K sold.

Nebula Research & Development first reported a position in WGS in Q4 2024 and held it in 1 quarter. The position peaked at $378K in Q4 2024. 225 funds tracked by Wall St. Rank hold WGS as of Q1 2025.

  • Nebula Research & Development reported no remaining GeneDx Holdings position as of Q1 2025 after selling out during the quarter.
  • Nebula Research & Development sold 4,918 GeneDx Holdings shares in Q1 2025, an estimated $378K.
  • Nebula Research & Development first reported a position in GeneDx Holdings in Q4 2024 and held it in 1 quarter.
  • Nebula Research & Development's GeneDx Holdings position peaked at $378K in Q4 2024.
  • 225 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2025.

Based on Nebula Research & Development's 13F filing for Q1 2025, filed 15 May 2025.